Highlands Oncology Group SC — Fayetteville, Arkansas

Highlands Oncology Group SC is a clinical research site located in Fayetteville, Arkansas, United States 72703.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Highlands Oncology Group SC has participated in 2 clinical trials.

Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib, Early Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Highlands Oncology Group SC?

Highlands Oncology Group SC has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Highlands Oncology Group SC conducted?

Highlands Oncology Group SC has 2 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib, Early Breast Cancer.

Is Highlands Oncology Group SC accredited by Crixeo Health?

Highlands Oncology Group SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Highlands Oncology Group SC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.